Sign In
Buy ILMN
$205.10
+0.0100 (+0.0049%)
At Close: Jul 31, 2026
Illumina Appoints Dr. Eric Green as Chief Medical Officer
04:30pm, Thursday, 08'th Jan 2026
Veteran genomics leader joins Illumina to advance global medical strategy Illumina chief commercial officer to depart for role as a life science tools company CEO SAN DIEGO, Jan. 8, 2026 /PRNewswire
Illumina and PREMIA partner to expand clinical access to CGP in Asia
08:07am, Thursday, 08'th Jan 2026
TAIPEI, Taiwan, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Illumina Taiwan Biotechnology Co., Ltd., and Precision Medicine Asia, Limited (PREMIA), a leading Asian cancer clinical-genomic screening network, tod
REGN vs. ILMN: Which Stock Is the Better Value Option?
12:41pm, Wednesday, 07'th Jan 2026
Investors interested in stocks from the Medical - Biomedical and Genetics sector have probably already heard of Regeneron (REGN) and Illumina (ILMN). But which of these two stocks offers value investo
REGN vs. ILMN: Which Stock Should Value Investors Buy Now?
12:41pm, Tuesday, 06'th Jan 2026
Investors interested in stocks from the Medical - Biomedical and Genetics sector have probably already heard of Regeneron (REGN) and Illumina (ILMN). But which of these two companies is the best optio
Illumina launches powerful software for connected, intuitive, and scalable multiomic analysis
09:15am, Tuesday, 06'th Jan 2026
Integrated software, AI-driven analytics, and frictionless workflows enable customers to harness the full power of biological insights SAN DIEGO, Jan. 6, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ: I
Generali Asset Management SPA SGR Has $2.11 Million Stock Position in Illumina, Inc. $ILMN
05:36am, Sunday, 04'th Jan 2026
Generali Asset Management SPA SGR increased its holdings in shares of Illumina, Inc. (NASDAQ: ILMN) by 51.6% in the third quarter, according to its most recent disclosure with the SEC. The firm owned
Diversified Trust Co Makes New $626,000 Investment in Illumina, Inc. $ILMN
05:37am, Saturday, 03'rd Jan 2026
Diversified Trust Co acquired a new position in shares of Illumina, Inc. (NASDAQ: ILMN) in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchang
Here's Why Illumina (ILMN) is a Strong Momentum Stock
10:50am, Wednesday, 31'st Dec 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Illumina (ILMN) Surges 3.3%: Is This an Indication of Further Gains?
08:16am, Monday, 22'nd Dec 2025
Illumina (ILMN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in t
Illumina Target of Unusually Large Options Trading (NASDAQ:ILMN)
01:46am, Thursday, 18'th Dec 2025
Illumina, Inc. (NASDAQ: ILMN - Get Free Report) was the recipient of some unusual options trading activity on Wednesday. Investors bought 4,552 call options on the company. This represents an increase
Can These 5 Relative Price Strength Stocks Lead in 2026?
11:16am, Wednesday, 17'th Dec 2025
U.S. stocks are heading toward the end of the year with clear momentum, as the major indexes continue to hover near record levels. While short-term pauses have appeared, they have been shallow, sugges
Illumina To Webcast Upcoming Investor Conference
04:05pm, Tuesday, 16'th Dec 2025
SAN DIEGO , Dec. 16, 2025 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced that members of its management team will participate at the following investor conference: Upcoming Investor Co
Why Illumina (ILMN) is a Top Momentum Stock for the Long-Term
10:51am, Friday, 12'th Dec 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Daiwa Securities Group Inc. Has $6.80 Million Holdings in Illumina, Inc. $ILMN
04:30am, Friday, 12'th Dec 2025
Daiwa Securities Group Inc. grew its holdings in Illumina, Inc. (NASDAQ: ILMN) by 10.7% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC)
Partnership unites Illumina's leading sequencing technology with cutting-edge clinical genomics analyses and AI to advance precision medicine for early detection and prevention. SAN DIEGO and MENLO PA
